Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Press Releases
Traws Pharma, Inc.  
December 23, 2024

Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu

Investigational agent in development for treatment or prevention of H5N1 Bird Flu

logo salamanca press

Salamanca Press

Local & Social